IPSC
HealthcareCentury Therapeutics, Inc.
$2.31-0.18 (-7.40%)
Prev Close
$2.50
Open
$2.48
High
$2.58
Low
$2.29
Volume
989.3K
Market Cap
$253.6M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Century Therapeutics, Inc. (IPSC) has been mixed between buying and selling, with 3 insider purchases totaling $96.9K and 19 insider sales totaling $96.1K. The most recent insider transaction was by Russotti Gregory (officer: See Remarks), who sold $1.2K worth of shares on Mar 11, 2026. Century Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $253.6M.
Buys (12M)
3
$96.9K
Sells (12M)
19
$96.1K
Net Activity
Net Buyer
$839.70
Active Insiders
7
last 12 mo
IPSC Price Chart
IPSC Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026↗ | Russotti Gregory | officer: See Remarks | Sell | 479 | $2.54 | $1.2K | 525,503 |
| Feb 18, 2026↗ | Pfeiffenberger Brent | President and CEO | Sell | 31,172 | $1.75 | $54.6K | 0 |
| Feb 5, 2026↗ | Carr Douglas | officer: SVP Finance & Operations | Sell | 323 | $1.82 | $588.51 | 514,551 |
| Dec 29, 2025↗ | Cowan Chad | Chief Scientific Officer | Buy | 58,060 | $0.85 | $49.3K | 1,045,090 |
| Dec 16, 2025↗ | Pfeiffenberger Brent | President and CEO | Buy | 52,000 | $0.58 | $30.4K | 3,322,990 |
| Dec 10, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 257 | $0.53 | $136.72 | 404,874 |
| Dec 10, 2025↗ | Russotti Gregory | See Remarks | Sell | 526 | $0.53 | $279.83 | 390,982 |
| Nov 24, 2025↗ | Cowan Chad | Chief Scientific Officer | Sell | 5,462 | $0.50 | $2.7K | 987,027 |
| Nov 20, 2025↗ | Pfeiffenberger Brent | President and CEO | Buy | 35,000 | $0.50 | $17.3K | 3,271,450 |
| Nov 19, 2025↗ | Pfeiffenberger Brent | President and CEO | Sell | 32,456 | $0.45 | $14.7K | 3,236,450 |
| Nov 5, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 292 | $0.59 | $171.11 | 405,131 |
| Sep 10, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 263 | $0.50 | $131.50 | 405,423 |
| Sep 10, 2025↗ | Pfeiffenberger Brent | President and CEO | Sell | 488 | $0.50 | $244.00 | 3,268,910 |
| Sep 10, 2025↗ | Russotti Gregory | See Remarks | Sell | 539 | $0.50 | $269.50 | 391,508 |
| Aug 6, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 296 | $0.53 | $158.06 | 405,686 |
| Jun 11, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 4,904 | $0.62 | $3.1K | 405,982 |
| Jun 11, 2025↗ | Farid Adrienne | Chief Operations Officer | Sell | 552 | $0.62 | $343.34 | 250,141 |
| Jun 11, 2025↗ | Pfeiffenberger Brent | President and CEO | Sell | 475 | $0.62 | $295.45 | 1,681,780 |
| Jun 11, 2025↗ | Russotti Gregory | See Remarks | Sell | 526 | $0.62 | $327.17 | 392,047 |
| May 20, 2025↗ | Pfeiffenberger Brent | President and CEO | Sell | 29,552 | $0.55 | $16.1K | 1,682,260 |
| May 7, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 295 | $0.55 | $162.25 | 410,886 |
| May 7, 2025↗ | Farid Adrienne | Chief Operations Officer | Sell | 1,024 | $0.55 | $563.20 | 250,693 |
| Mar 12, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 1,240 | $0.62 | $762.60 | 315,556 |
| Mar 12, 2025↗ | Farid Adrienne | Chief Operations Officer | Sell | 2,359 | $0.62 | $1.5K | 131,717 |
| Mar 12, 2025↗ | Pfeiffenberger Brent | President and CEO | Sell | 2,235 | $0.62 | $1.4K | 1,190,310 |
| Mar 12, 2025↗ | Russotti Gregory | See Remarks | Sell | 2,360 | $0.62 | $1.5K | 272,573 |
| Feb 20, 2025↗ | Pfeiffenberger Brent | President and CEO | Sell | 34,712 | $0.78 | $27.2K | 1,192,540 |
| Feb 5, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 351 | $0.78 | $273.78 | 316,796 |
| Feb 5, 2025↗ | Farid Adrienne | Chief Operations Officer | Sell | 1,054 | $0.78 | $822.12 | 134,076 |
| Nov 5, 2024↗ | Carr Douglas | SVP Finance & Operations | Sell | 283 | $1.23 | $347.24 | 317,147 |
| Nov 5, 2024↗ | Farid Adrienne | Chief Operations Officer | Sell | 1,033 | $1.23 | $1.3K | 135,130 |
| Sep 16, 2024↗ | Quimi Daphne | Director | Buy | 5,000 | $1.53 | $7.7K | 5,000 |
| Aug 7, 2024↗ | Carr Douglas | SVP Finance & Operations | Sell | 289 | $1.83 | $528.00 | 334,041 |
| Aug 7, 2024↗ | Farid Adrienne | Chief Operations Officer | Sell | 1,073 | $1.83 | $2.0K | 136,163 |
| Jul 31, 2024↗ | Russotti Gregory | See Remarks | Sell | 586 | $2.50 | $1.5K | 274,933 |
| Jul 25, 2024↗ | Russotti Gregory | See Remarks | Sell | 1,800 | $2.52 | $4.5K | 277,119 |
| Jun 24, 2024↗ | Russotti Gregory | See Remarks | Sell | 5,000 | $2.84 | $14.2K | 277,319 |
| Jun 6, 2024↗ | Russotti Gregory | See Remarks | Sell | 5,000 | $3.00 | $15.0K | 282,319 |
| May 21, 2024↗ | Russotti Gregory | See Remarks | Sell | 5,000 | $3.00 | $15.0K | 287,319 |
| May 7, 2024↗ | Carr Douglas | SVP Finance & Operations | Sell | 257 | $3.11 | $798.24 | 317,323 |
| May 7, 2024↗ | Farid Adrienne | Chief Operations Officer | Sell | 913 | $3.11 | $2.8K | 137,236 |
| May 7, 2024↗ | Russotti Gregory | See Remarks | Sell | 5,000 | $3.12 | $15.6K | 292,319 |
| Apr 24, 2024↗ | Russotti Gregory | See Remarks | Sell | 5,000 | $3.10 | $15.5K | 297,319 |
| Mar 8, 2024↗ | Farid Adrienne | Chief Operations Officer | Sell | 53,515 | $5.04 | $269.7K | 114,149 |
| Feb 21, 2024↗ | Farid Adrienne | Chief Operations Officer | Sell | 485 | $4.86 | $2.4K | 114,149 |
| Feb 7, 2024↗ | Carr Douglas | SVP Finance & Operations | Sell | 1,200 | $4.14 | $5.0K | 304,137 |
| Feb 7, 2024↗ | Farid Adrienne | Chief Operations Officer | Sell | 3,819 | $4.14 | $15.8K | 115,933 |
| Mar 23, 2023↗ | Borges Luis | Chief Scientific Officer | Sell | 144,911 | $3.73 | $539.9K | 249,083 |
| Aug 11, 2022↗ | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 550,000 | $13.03 | $7.17M | 11,816,800 |
| Jun 23, 2021↗ | BAYER AKTIENGESELLSCHAFT | 10% Owner | Buy | 750,000 | $20.00 | $15.00M | 12,675,800 |
| Jun 23, 2021↗ | Versant Venture Capital VI, L.P. | 10% Owner | Buy | 100,000 | $20.00 | $2.00M | 714,095 |
| Jun 22, 2021↗ | Casdin Eli | Director | Buy | 750,000 | $20.00 | $15.00M | 3,206,380 |
IPSC Insider Buying Activity
The following table shows recent insider purchases of Century Therapeutics, Inc. (IPSC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 29, 2025↗ | Cowan Chad | Chief Scientific Officer | Buy | 58,060 | $0.85 | $49.3K | 1,045,090 |
| Dec 16, 2025↗ | Pfeiffenberger Brent | President and CEO | Buy | 52,000 | $0.58 | $30.4K | 3,322,990 |
| Nov 20, 2025↗ | Pfeiffenberger Brent | President and CEO | Buy | 35,000 | $0.50 | $17.3K | 3,271,450 |
| Sep 16, 2024↗ | Quimi Daphne | Director | Buy | 5,000 | $1.53 | $7.7K | 5,000 |
| Jun 23, 2021↗ | BAYER AKTIENGESELLSCHAFT | 10% Owner | Buy | 750,000 | $20.00 | $15.00M | 12,675,800 |
| Jun 23, 2021↗ | Versant Venture Capital VI, L.P. | 10% Owner | Buy | 100,000 | $20.00 | $2.00M | 714,095 |
| Jun 22, 2021↗ | Casdin Eli | Director | Buy | 750,000 | $20.00 | $15.00M | 3,206,380 |
IPSC Insider Selling Activity
The following table shows recent insider sales of Century Therapeutics, Inc. (IPSC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026↗ | Russotti Gregory | officer: See Remarks | Sell | 479 | $2.54 | $1.2K | 525,503 |
| Feb 18, 2026↗ | Pfeiffenberger Brent | President and CEO | Sell | 31,172 | $1.75 | $54.6K | 0 |
| Feb 5, 2026↗ | Carr Douglas | officer: SVP Finance & Operations | Sell | 323 | $1.82 | $588.51 | 514,551 |
| Dec 10, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 257 | $0.53 | $136.72 | 404,874 |
| Dec 10, 2025↗ | Russotti Gregory | See Remarks | Sell | 526 | $0.53 | $279.83 | 390,982 |
| Nov 24, 2025↗ | Cowan Chad | Chief Scientific Officer | Sell | 5,462 | $0.50 | $2.7K | 987,027 |
| Nov 19, 2025↗ | Pfeiffenberger Brent | President and CEO | Sell | 32,456 | $0.45 | $14.7K | 3,236,450 |
| Nov 5, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 292 | $0.59 | $171.11 | 405,131 |
| Sep 10, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 263 | $0.50 | $131.50 | 405,423 |
| Sep 10, 2025↗ | Pfeiffenberger Brent | President and CEO | Sell | 488 | $0.50 | $244.00 | 3,268,910 |
| Sep 10, 2025↗ | Russotti Gregory | See Remarks | Sell | 539 | $0.50 | $269.50 | 391,508 |
| Aug 6, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 296 | $0.53 | $158.06 | 405,686 |
| Jun 11, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 4,904 | $0.62 | $3.1K | 405,982 |
| Jun 11, 2025↗ | Farid Adrienne | Chief Operations Officer | Sell | 552 | $0.62 | $343.34 | 250,141 |
| Jun 11, 2025↗ | Pfeiffenberger Brent | President and CEO | Sell | 475 | $0.62 | $295.45 | 1,681,780 |
| Jun 11, 2025↗ | Russotti Gregory | See Remarks | Sell | 526 | $0.62 | $327.17 | 392,047 |
| May 20, 2025↗ | Pfeiffenberger Brent | President and CEO | Sell | 29,552 | $0.55 | $16.1K | 1,682,260 |
| May 7, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 295 | $0.55 | $162.25 | 410,886 |
| May 7, 2025↗ | Farid Adrienne | Chief Operations Officer | Sell | 1,024 | $0.55 | $563.20 | 250,693 |
| Mar 12, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 1,240 | $0.62 | $762.60 | 315,556 |
| Mar 12, 2025↗ | Farid Adrienne | Chief Operations Officer | Sell | 2,359 | $0.62 | $1.5K | 131,717 |
| Mar 12, 2025↗ | Pfeiffenberger Brent | President and CEO | Sell | 2,235 | $0.62 | $1.4K | 1,190,310 |
| Mar 12, 2025↗ | Russotti Gregory | See Remarks | Sell | 2,360 | $0.62 | $1.5K | 272,573 |
| Feb 20, 2025↗ | Pfeiffenberger Brent | President and CEO | Sell | 34,712 | $0.78 | $27.2K | 1,192,540 |
| Feb 5, 2025↗ | Carr Douglas | SVP Finance & Operations | Sell | 351 | $0.78 | $273.78 | 316,796 |
| Feb 5, 2025↗ | Farid Adrienne | Chief Operations Officer | Sell | 1,054 | $0.78 | $822.12 | 134,076 |
| Nov 5, 2024↗ | Carr Douglas | SVP Finance & Operations | Sell | 283 | $1.23 | $347.24 | 317,147 |
| Nov 5, 2024↗ | Farid Adrienne | Chief Operations Officer | Sell | 1,033 | $1.23 | $1.3K | 135,130 |
| Aug 7, 2024↗ | Carr Douglas | SVP Finance & Operations | Sell | 289 | $1.83 | $528.00 | 334,041 |
| Aug 7, 2024↗ | Farid Adrienne | Chief Operations Officer | Sell | 1,073 | $1.83 | $2.0K | 136,163 |
| Jul 31, 2024↗ | Russotti Gregory | See Remarks | Sell | 586 | $2.50 | $1.5K | 274,933 |
| Jul 25, 2024↗ | Russotti Gregory | See Remarks | Sell | 1,800 | $2.52 | $4.5K | 277,119 |
| Jun 24, 2024↗ | Russotti Gregory | See Remarks | Sell | 5,000 | $2.84 | $14.2K | 277,319 |
| Jun 6, 2024↗ | Russotti Gregory | See Remarks | Sell | 5,000 | $3.00 | $15.0K | 282,319 |
| May 21, 2024↗ | Russotti Gregory | See Remarks | Sell | 5,000 | $3.00 | $15.0K | 287,319 |
| May 7, 2024↗ | Carr Douglas | SVP Finance & Operations | Sell | 257 | $3.11 | $798.24 | 317,323 |
| May 7, 2024↗ | Farid Adrienne | Chief Operations Officer | Sell | 913 | $3.11 | $2.8K | 137,236 |
| May 7, 2024↗ | Russotti Gregory | See Remarks | Sell | 5,000 | $3.12 | $15.6K | 292,319 |
| Apr 24, 2024↗ | Russotti Gregory | See Remarks | Sell | 5,000 | $3.10 | $15.5K | 297,319 |
| Mar 8, 2024↗ | Farid Adrienne | Chief Operations Officer | Sell | 53,515 | $5.04 | $269.7K | 114,149 |
| Feb 21, 2024↗ | Farid Adrienne | Chief Operations Officer | Sell | 485 | $4.86 | $2.4K | 114,149 |
| Feb 7, 2024↗ | Carr Douglas | SVP Finance & Operations | Sell | 1,200 | $4.14 | $5.0K | 304,137 |
| Feb 7, 2024↗ | Farid Adrienne | Chief Operations Officer | Sell | 3,819 | $4.14 | $15.8K | 115,933 |
| Mar 23, 2023↗ | Borges Luis | Chief Scientific Officer | Sell | 144,911 | $3.73 | $539.9K | 249,083 |
| Aug 11, 2022↗ | Versant Venture Capital VI, L.P. | 10% Owner | Sell | 550,000 | $13.03 | $7.17M | 11,816,800 |
IPSC Insiders
Similar Stocks to IPSC
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B